Verona Pharma reports positive results from RPL554 dose-finding study
Verona Pharma reports positive results from RPL554 dose-finding study
Pharmaceuticals, Biotechnology and Life Sciences
Verona Pharma reports positive results from RPL554 dose-finding study
MedMined Surveillance Advisor named “the best technology for Infection Control and Monitoring”
On January 28, 2016, the United States Food and Drug Administration (FDA) approved Zepatier (elbasvir and grazoprevir) for the treatment of chronic genotype 1 or 4 hepatitis C virus (HCV) infection in adults.
J&J has annonced that results of a new analysis of data from real-world clinical practice show that, in adults with type 2 diabetes
Scientists have long been interested in how the vascular system — the body’s network of large and small blood vessels — may be involved in the onset and progression of Alzheimer’s disease and related dementias.
Making the most of the low light in the muddy rivers where it swims, the elephant nose fish survives…
United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance to Horizon Pharma for U.S. patent application number…
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab…
Sanofi welcomes new Executive Committee member
Premaitha signs distribution agreement with GeNext in Russia